<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0006761</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3392</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Med Child Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev Med Child Neurol</journal-id>
<journal-title-group>
<journal-title>Developmental medicine and child neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0012-1622</issn>
<issn pub-type="epub">1469-8749</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26510705</article-id>
<article-id pub-id-type="pmc">4848162</article-id>
<article-id pub-id-type="doi">10.1111/dmcn.12948</article-id>
<article-id pub-id-type="manuscript">NIHMS775061</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>JOHNSON</surname>
<given-names>NICHOLAS E</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>EKSTROM</surname>
<given-names>ANNE-BERIT</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>CAMPBELL</surname>
<given-names>CRAIG</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>HUNG</surname>
<given-names>MAN</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>ADAMS</surname>
<given-names>HEATHER R</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>CHEN</surname>
<given-names>WEI</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>LUEBBE</surname>
<given-names>ELIZABETH</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>HILBERT</surname>
<given-names>JAMES</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>MOXLEY</surname>
<given-names>RICHARD T</given-names>
<suffix>III</suffix>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>HEATWOLE</surname>
<given-names>CHAD R</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Neurology, The University of Utah, Salt Lake City, UT, USA</aff>
<aff id="A2"><label>2</label>Department of Pediatrics, The Queen Silvia Children’s Hospital, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden</aff>
<aff id="A3"><label>3</label>Department of Neurology, London Health Science Centre, London, ON, Canada</aff>
<aff id="A4"><label>4</label>Department of Orthopedics, The University of Utah, Salt Lake City, UT</aff>
<aff id="A5"><label>5</label>Division of Epidemiology, The University of Utah, Salt Lake City, UT</aff>
<aff id="A6"><label>6</label>Department of Neurology, The University of Rochester, Rochester, NY, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence to Nicholas E Johnson, 30 N 1900 SOM 3E228, Salt Lake City, UT 84132, USA. <email>Nicholas.johnson@hsc.utah.edu</email></corresp>
<fn fn-type="conflict" id="FN2">
<p>The authors have stated that they had no interests that might be perceived as posing a conflict or bias.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>58</volume>
<issue>7</issue>
<fpage>698</fpage>
<lpage>705</lpage>
<!--elocation-id from pubmed: 10.1111/dmcn.12948-->
<abstract>
<sec id="S1">
<title>AIM</title>
<p id="P1">The frequency and impact of symptoms experienced by patients with congenital, childhood, and juvenile-onset myotonic dystrophy (CDM/ChDM/JDM) is not documented. This report identifies symptomatic areas with the greatest disease burden in an international population of patients with early-onset myotonic dystrophy type-1 (DM1).</p>
</sec>
<sec id="S2">
<title>METHOD</title>
<p id="P2">We distributed surveys to parents of patients with CDM/ChDM/JDM. Patients with CDM/ChDM/JDM were members of the US National Registry of DM1 Patients and Family Members, the Canadian Neuromuscular Disease Registry, or the Swedish Health System. Surveys inquired about 325 symptoms and 20 themes associated with CDM/ChDM/JDM. Parents identified the importance of each symptom and theme to their affected child. The prevalence of each symptom and theme were compared across subgroups of patients. The statistical analysis was performed using Fisher’s exact and Kruskal–Wallis tests.</p>
</sec>
<sec id="S3">
<title>RESULTS</title>
<p id="P3">One hundred and fifty parents returned surveys. The most frequently reported symptomatic themes in children were issues involving communication (81.7%) and problems with hands or fingers (79.6%). Problems with communication and fatigue were the issues that were reported to have the greatest impact on childrens’ lives, while 24.1% of children reported cardiac disorders and 15.8% had problems with anesthesia.</p>
</sec>
<sec id="S4">
<title>INTERPRETATION</title>
<p id="P4">A range of symptoms contribute to the burden of disease faced by children with DM1. Many of these symptoms are under-recognized.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>